PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsIpx066
Ipx066
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
237 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Parkinson diseaseD010300EFO_0002508G204145392029164
DepressionD003863—F33.9—1—517
Depressive disorderD003866EFO_1002014F32.A—2—5—7
StrokeD020521EFO_0000712I63.9122227
DyskinesiasD020820—G24113116
Back painD001416—M54—2—1—3
Neurologic gait disordersD020233—R26.1—1—113
AnhedoniaD059445—R45.84———2—2
Cognitive dysfunctionD060825—G31.84—1—1—2
Major depressive disorderD003865EFO_0003761F22—1—1—2
Show 15 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cocaine-related disordersD019970—F14—61—17
Spinal cord injuriesD013119EFO_1001919—321——4
SyndromeD013577——111—13
Angelman syndromeD017204Orphanet_72Q93.51111—13
DiseaseD004194EFO_0000408R691—1——2
AmblyopiaD000550—H53.00—11——2
Stroke rehabilitationD000071939————1——1
AphasiaD001037—R47.01—11——1
Broca aphasiaD001039———11——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Macular degenerationD008268EFO_0001365H35.30—5———5
HypotensionD007022EFO_0005251I9521———2
Orthostatic hypotensionD007024—I95.121———2
Shy-drager syndromeD012791EFO_1001050—11——12
Multiple system atrophyD019578——11——12
AtrophyD001284——12———2
Acute painD059787—R52—2———2
Wounds and injuriesD014947—T14.821———2
Opioid-related disordersD009293EFO_0005611F11—1——12
Chronic painD059350———2———2
Show 16 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———8————8
Diabetic retinopathyD003930EFO_0003770—2————2
Pure autonomic failureD054970——1————1
PharmacokineticsD010599——1————1
MothersD009035——1————1
Amyotrophic lateral sclerosisD000690EFO_0000253G12.211————1
Motor neuron diseaseD016472EFO_0003782G12.21————1
SclerosisD012598——1————1
AmyloidosisD000686EFO_1001875E851————1
Disease progressionD018450——1————1
Show 3 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Parkinsonian disordersD020734—G20.C————22
Nervous system diseasesD009422—G00-G99————11
Huntington diseaseD006816Orphanet_399G10————11
Progressive supranuclear palsyD013494EFO_0002512G23.1————11
Corticobasal degenerationD000088282—G31.85————11
NarcolepsyD009290EFO_0000614G47.4————11
Sleep wake disordersD012893—G47————11
ParasomniasD020447—G47.5————11
SleepinessD000077260—R40.0————11
Memory consolidationD000069077——————11
Show 3 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use